Molecular Cross-Talk between the NFκB and STAT3 Signaling Pathways in Head and Neck Squamous Cell Carcinoma
Open Access
- 1 September 2006
- Vol. 8 (9) , 733-746
- https://doi.org/10.1593/neo.06274
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck CancerCancer Research, 2006
- NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinomaPublished by Elsevier ,2005
- Immunobiology of head and neck cancerCancer and Metastasis Reviews, 2005
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- Complex Regulation of Signal Transducers and Activators of Transcription 3 Activation in Normal and Malignant KeratinocytesCancer Research, 2004
- Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neckCytokine, 2004
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.Journal of Clinical Investigation, 1998
- ETS1, NFκB and AP1 synergistically transactivate the human GM – CSF promoterOncogene, 1997
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994